Home Awards and Honors Media Placements Bridging the Cultural Gap Links Contact

News Archive

 

“Behind the Buzz” Show: FSD Pharma Inc. CEO & Co-Chairman Raza Bokhari

February 13th, 2020

FSD Pharma CEO, Dr. Raza Bokhari with Rebecca Urena on “Behind the Buzz” at BIO CEO & Investor Conference NYC states chronic inflammation is the subset of most diseases and we believe that through our lead compound, Micro PEA, we have a potential opportunity to create novel opioid sparing prescription medications that can help address the opioid crisis.

Click here to watch the video.

Email to a friend


FSD Pharma advancing its Phase 1 study in Australia

February 10th, 2020

Dr Raza Bokhari at BIO CEO & Investor Conference NYC, says Nucleus Network to conduct Phase 1 in human safety & tolerability study of FSD Pharma's lead candidate PP101 ultra micro PEA in Australia.

Click here to watch the video

Email to a friend


Dr. Raza Bokhari on the Real Promise of CBD

March 19, 2020

Dr Raza Bokhari, Chairman & CEO, FSD Pharma recently joined CSE’s Barrington Miller on Hashtag Finance, Talking about  Ultra Micro PEA and it's tremendous potential anti-inflammatory drug 

Click here to watch the video.

Market Open at the CSE: FSD Pharma, Inc

March 18, 2020

Dr. Raza Bokhari, CEO, FSD Pharma at CSE opening  bell ringing ceremony making FSD Pharma (Nasdaq: HUGE) 1st CSE company dual listed in United States.

Click here to watch the video.

FSD Pharma rings the bell to open trading day on the Canadian Securities Exchange

March 6th, 2020

FSD Pharma CEO, Dr Raza Bokhari, with Steve Darling from Proactive Investors Vancouver, said this bell ringing was especially meaningful because FSD’s first in human safety & tolerability study has been formally approved and will be commencing in Australia later this month.

Click here to watch the video.

View Archive
Home | Awards and Honors | Media Placements | Bridging the Cultural Gap | Links | Contact © 2007 Dr. Raza Bokhari · All rights reserved.